MedX Health Corp. Announces Private Placement Closing



MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announces that,
pursuant to a non-brokered Private Placement Offering (the “Placement
Offering”), it has completed an initial Closing of 2,106,250 Units, to
raise $337,000 from accredited investors. The Company is planning to
raise up to $2.5 million by issuance of up to 15,625,000 Units from the
Placement Offering. Each Unit, priced at $0.16, comprises one fully paid
common share and one share purchase warrant; each warrant entitles the
holder to purchase one additional share at a price of $0.35 during the
period up to three years from the closing date of the placement. The
securities issued as a result of the Placement Offering will be
restricted from trading for four months following each Closing. The
Placement Offering is still open to subscribers, and further
subscriptions may be accepted for further Closings. This Closing, and
any further Closing of the Placement Offering, is subject to all
relevant regulatory and other consents and approvals, including
acceptance by the TSX Venture Exchange.

Following this Closing, MedX has 133,916,401 common shares issued and

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device
and software company focused on skin cancer with its DermSecure™
telemedicine platform, utilizing its SIAscopy technology. SIAscopy is
also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which
MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™,
SIMSYS™, and MoleMate™ include hand-held devices that use patented
technology utilizing light and its remittance to view up to 2 mm beneath
suspicious moles and lesions in a pain free, non-invasive manner, with
its software then creating real-time images for physicians and
dermatologists to evaluate all types of moles or lesions within seconds.
These products are Health Canada, FDA (US), ARTG and CE cleared for use
in Canada, the US, Australia, New Zealand, the European Union and
Turkey. MedX also designs, manufactures and distributes quality
photobiomodulation therapeutic and dental lasers to provide drug-free
and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

This press release does not constitute an offer of any securities for
sale. This press release contains certain forward-looking statements
within the meaning of applicable Canadian securities legislation. These
forward-looking statements involve certain risks and uncertainties that
could cause actual results to differ, including, without limitation, the
company’s limited operating history and history of losses, the inability
to successfully obtain further funding, the inability to raise capital
on terms acceptable to the company, the inability to compete effectively
in the marketplace, the inability to complete the proposed acquisition
and such other risks that could cause the actual results to differ
materially from those contained in the company’s projections or
forward-looking statements. All forward looking statements in this press
release are based on information available to the company as of the date
hereof, and the company undertakes no obligation to update
forward-looking statements to reflect events or circumstances occurring
after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this press release.


MedX Health Corp
Scott Spearn, 905-670-4428 ext 229
and CEO
Media Relations
Deborah Thompson,


I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.